BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank57
3Y CAGR-33.5%
5Y CAGR-19.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-33.5%/yr
vs +83.8%/yr prior
5Y CAGR
-19.9%/yr
Recent deceleration
Acceleration
-117.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $89.74M | -14.5% |
| 2024 | $104.92M | -5.2% |
| 2023 | $110.64M | -63.7% |
| 2022 | $304.77M | -39.6% |
| 2021 | $504.39M | +85.4% |
| 2020 | $272.13M | +138.3% |
| 2019 | $114.17M | +327.1% |
| 2018 | $26.73M | -46.8% |
| 2017 | $50.28M | +127.5% |
| 2016 | $22.10M | - |